Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jenny Nyqvist"'
Autor:
Jenny Nyqvist, Anikó Kovács, Zakaria Einbeigi, Per Karlsson, Eva Forssell‐Aronsson, Khalil Helou, Toshima Z. Parris
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4465-4477 (2021)
Abstract Breast cancer (BC) patients are frequently at risk of developing other malignancies following treatment. Although studies have been conducted to elucidate the etiology of multiple primary malignancies (MPM) after a BC diagnosis, few studies
Externí odkaz:
https://doaj.org/article/5121f7cc3e0a44468a4aa27180db5890
Autor:
Shahin De Lara, Jenny Nyqvist, Elisabeth Werner Rönnerman, Khalil Helou, Elisabeth Kenne Sarenmalm, Zakaria Einbeigi, Per Karlsson, Toshima Z. Parris, Anikó Kovács
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Current prognostic markers cannot adequately predict the clinical outcome of breast cancer patients. Therefore, additional biomarkers need to be included in routine immune panels. FOXA1 was a significant predictor of favorable out
Externí odkaz:
https://doaj.org/article/2be111e7cbf64b5abd118e8e2bc64d59
Autor:
Jenny Nyqvist, Fredrik Persson, Toshima Z. Parris, Khalil Helou, Elisabeth Kenne Sarenmalm, Zakaria Einbeigi, Åke Borg, Per Karlsson, Anikó Kovács
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1006-1012 (2017)
The number of patients with multiple primary malignancies has been increasing steadily in recent years. In the present study, we describe a unique case of an 81-year-old woman with 5 metachronous and synchronous primary malignant neoplasms. The patie
Externí odkaz:
https://doaj.org/article/f157f02379e64a09a720737a7bc7bee0
Autor:
Khalil Helou, Jenny Nyqvist, Anikó Kovács, Toshima Z. Parris, Per Karlsson, Eva Forssell-Aronsson, Zakaria Einbeigi
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4465-4477 (2021)
Cancer Medicine
Cancer Medicine
Breast cancer (BC) patients are frequently at risk of developing other malignancies following treatment. Although studies have been conducted to elucidate the etiology of multiple primary malignancies (MPM) after a BC diagnosis, few studies have inve
Autor:
Khalil Helou, Per Karlsson, Anikó Kovács, Zakaria Einbeigi, Salmir Nasic, Jenny Nyqvist, Elisabeth Kenne Sarenmalm, Toshima Z. Parris
Publikováno v:
Breast Cancer Research and Treatment
Purpose Multiple primary malignancies (MPMs) caused by breast cancer treatment are well described, but only few studies to date describe which other previous primary malignancies (OPPMs) occur before breast cancer. The purpose of the present study wa
Autor:
Jenny Nyqvist, S. De Lara, E. Kenne Sarenmalm, Khalil Helou, A. Kovács, Per Karlsson, Zakaria Einbeigi, Toshima Z. Parris
Publikováno v:
Cancer Research. 79:P2-08
Background. Including additional genes in standard immunohistochemical panels might be helpful in determining the prognosis of breast cancer patients. Pevious studies have shown that FOXA1 is a significant predictor of good outcome in breast cancer,
Autor:
Elisabeth Kenne Sarenmalm, Toshima Z. Parris, Jenny Nyqvist, Fredrik Persson, Åke Borg, Khalil Helou, Per Karlsson, Anikó Kovács, Zakaria Einbeigi
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1006-1012 (2017)
Case Reports in Oncology
Case Reports in Oncology
The number of patients with multiple primary malignancies has been increasing steadily in recent years. In the present study, we describe a unique case of an 81-year-old woman with 5 metachronous and synchronous primary malignant neoplasms. The patie
Publikováno v:
The Breast. 32:S38-S39